Emancipation Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-16,800
Closed -$1.75M 47
2017
Q4
$1.75M Hold
16,800
2.95% 11
2017
Q3
$2.45M Hold
16,800
3.51% 7
2017
Q2
$2.18M Hold
16,800
3.59% 6
2017
Q1
$2.09M Hold
16,800
3.12% 5
2016
Q4
$1.94M Hold
16,800
3.18% 7
2016
Q3
$1.76M Sell
16,800
-919
-5% -$99.5K 2.71% 12
2016
Q2
$1.75M Sell
17,719
-761
-4% -$78.7K 2.13% 15
2016
Q1
$1.85M Hold
18,480
2.42% 9
2015
Q4
$20M Hold
18,480
18.7% 1
2015
Q3
$20M Hold
18,480
18.68% 1
2015
Q2
$2.14M Buy
+18,480
New +$2.11M 1.76% 16

Other funds holding CELG

Emancipation Management's CELG Position: Q1 2018 in Review

Emancipation Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 16,800 shares — an estimated $1.75M sold.

Emancipation Management first reported a position in CELG in Q2 2015 and held it in 11 quarters. The position peaked at $20M in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Emancipation Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Emancipation Management sold 16,800 Celgene Corp shares in Q1 2018, an estimated $1.75M.
  • Emancipation Management first reported a position in Celgene Corp in Q2 2015 and held it in 11 quarters.
  • Emancipation Management's Celgene Corp position peaked at $20M in Q4 2015.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Emancipation Management's 13F filing for Q1 2018, filed 11 May 2018.